Case Study: Helping a Health Tech Company Escape a High-Interest Debt Trap & Secure Sustainable Financing

Client Background
A rapidly growing health tech start-up had secured a high-interest loan to fuel its expansion. While the capital infusion enabled initial growth, the loan structure was highly aggressive—the principal increased by 50% annually, leading to an unsustainable cash burn rate.
The Challenge
The company found itself in a financial bind:
- The high-interest loan added significant pressure to its cash flow, increasing the risk of running out of operating capital.
- Traditional lenders were hesitant to refinance due to a lack of structured financial forecasting.
- The company’s leadership needed a clear financial case to justify a switch to a more sustainable loan structure.
How FinSysa Helped
FinSysa stepped in to provide strategic FP&A support and a data-driven approach to refinancing. Our key initiatives included:
- Built Long-Term Cash Flow Projections – Developed a detailed financial model illustrating how the high-interest debt impacted future cash flow and sustainability.
- Scenario Analysis for Refinancing – Compared the current loan structure with alternative financing options, demonstrating that a traditional loan would significantly reduce cash burn and extend the company’s financial runway.
- Investor & Lender-Ready Financials – Packaged the financial projections into a compelling narrative, making it easier to present to lenders and secure refinancing approval.
- Successful Refinancing Execution – With our support, the company secured a traditional loan at significantly lower interest rates, reducing the financial strain and allowing them to reinvest in growth.
The Results
- 40% Debt Reduction – The new loan structure eliminated the compounding debt issue, cutting financing costs significantly.
- Extended Cash Runway – With a lower debt burden, the company gained 7+ months of additional operating capital.
- Stronger Financial Health – The business became far more sustainable, with improved investor confidence and a healthier balance sheet.
Conclusion
By leveraging FinSysa’s long-term cash projections and financial strategy, this health tech company escaped a high-interest debt spiral, secured better financing, and positioned itself for long-term success—without sacrificing growth.
Struggling with debt-heavy cash burn? Let’s talk about how FinSysa can help.


Kevin Hummel